INSIGNEO ADVISORY SERVICES, LLC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1964958
MIAMI, FL
Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$203,040
+$74,456 QoQ
Shares Held
12,000
+19.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#213
of 330 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INSIGNEO ADVISORY SERVICES, LLC holds $3,685,699 across 13 Biotechnology names. NTLA ranks #8 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
10,847 | $591,595 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
104,252 | $549,407 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
958 | $475,866 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
742 | $462,666 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
6,341 | $298,280 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
1,010 | $287,819 | |
| 7 | INSM |
INSMED Inc
|
1,995 | $212,706 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
This page
|
12,000 | $203,040 |
All Filings in NTLA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $203,040 | 12,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $128,584 | 10,030 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $90,169 | 10,030 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||